- Home
- RFL vs VERI Comparison
RFL vs VERI Comparison
Compare RFL & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RFL | VERI |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.6M | 95.7M |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RFL | VERI |
|---|---|---|
| Price | $1.92 | $1.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 99.7K | ★ 2.2M |
| Earning Date | 06-10-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $917,000.00 | ★ $92,637,000.00 |
| Revenue This Year | N/A | $52.20 |
| Revenue Next Year | N/A | $3.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $1.12 | $0.98 |
| 52 Week High | $3.96 | $9.42 |
Technical Indicators
Market Signals| Indicator | RFL | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 42.20 | 66.78 |
| Support Level | $1.86 | $1.27 |
| Resistance Level | $3.96 | $1.54 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 11.76 | 93.27 |
Price Performance
Historical ComparisonAbout RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.